US5744460A
(en)
*
|
1996-03-07 |
1998-04-28 |
Novartis Corporation |
Combination for treatment of proliferative diseases
|
WO1999005160A2
(en)
*
|
1997-07-25 |
1999-02-04 |
Hybridon, Inc. |
Oligonuclotides having 3' terminal stereospecific phosphorothioates
|
JP2002510644A
(ja)
|
1998-04-03 |
2002-04-09 |
ユニバーシティ オブ アイオワ リサーチ ファウンデーション |
免疫治療用オリゴヌクレオチドおよびサイトカインを用いる免疫系刺激のための方法および産物
|
US6867294B1
(en)
*
|
1998-07-14 |
2005-03-15 |
Isis Pharmaceuticals, Inc. |
Gapped oligomers having site specific chiral phosphorothioate internucleoside linkages
|
US6242589B1
(en)
*
|
1998-07-14 |
2001-06-05 |
Isis Pharmaceuticals, Inc. |
Phosphorothioate oligonucleotides having modified internucleoside linkages
|
WO2000006588A1
(en)
*
|
1998-07-27 |
2000-02-10 |
University Of Iowa Research Foundation |
STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS
|
TW201006846A
(en)
|
2000-03-07 |
2010-02-16 |
Senomyx Inc |
T1R taste receptor and genes encidung same
|
TW201022287A
(en)
|
2001-01-03 |
2010-06-16 |
Senomyx Inc |
T1R taste receptors and genes encoding same
|
WO2002092006A2
(en)
|
2001-05-16 |
2002-11-21 |
Micrologix Biotech, Inc. |
Nucleic acid-based compounds and methods of use thereof
|
EP2003451B1
(en)
|
2001-06-26 |
2012-05-30 |
Senomyx, Inc. |
T1r1-t1r3 hetero-oligomeric umami taste receptors and cell lines that express said receptors and use thereof for identification of umami taste compounds
|
US6916621B2
(en)
|
2002-03-27 |
2005-07-12 |
Spectral Genomics, Inc. |
Methods for array-based comparitive binding assays
|
BRPI0309391B1
(pt)
|
2002-04-19 |
2018-10-30 |
Dsm Food Specialties B V |
vetor compreendendo ácido nucléico que codifica polipeptídeo com atividade de fosfolipase, célula transformada, preparado de proteína, método de preparação e métodos relacionados
|
US7226771B2
(en)
|
2002-04-19 |
2007-06-05 |
Diversa Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
WO2004074439A2
(en)
|
2003-02-14 |
2004-09-02 |
Biogen Idec Ma Inc. |
An expression cassette and vector for transient or stable expression of exogenous molecules
|
EP3508578A1
(en)
|
2003-03-06 |
2019-07-10 |
BASF Enzymes, LLC |
Amylases, nucleic acids encoding them and methods for making and using them
|
EP2853593B1
(en)
|
2003-03-07 |
2017-10-04 |
DSM IP Assets B.V. |
Hydrolases, nucleic acids encoding them and mehods for making and using them
|
HUE030493T2
(en)
|
2003-04-04 |
2017-05-29 |
Basf Enzymes Llc |
Pectate lyases, nucleic acids and processes encoding them for their production and use
|
US7960148B2
(en)
|
2003-07-02 |
2011-06-14 |
Verenium Corporation |
Glucanases, nucleic acids encoding them and methods for making and using them
|
RU2006106920A
(ru)
|
2003-08-06 |
2007-09-20 |
Синомикс Инк. (Us) |
Гетеро-олигомерные вкусовые рецепторы t1r, клеточные линии, которые экспрессируют указанные рецепторы и вкусовые соединения
|
CA2891101A1
(en)
|
2003-08-11 |
2005-03-10 |
Basf Enzymes Llc |
Laccases, nucleic acids encoding them and methods for making and using them
|
EP2468853B1
(en)
|
2004-06-16 |
2015-04-01 |
DSM IP Assets B.V. |
Method for enzymatic decolorization of pheophytin
|
US8821884B2
(en)
|
2004-07-27 |
2014-09-02 |
The Regents Of The University Of California |
Compositions and methods using MD-2 mutants and chimeric proteins
|
EP2886658A1
(en)
|
2005-03-10 |
2015-06-24 |
BASF Enzymes LLC |
Lyase enzymes, nucleic acids encoding them and methods for making and using them
|
CA2861310A1
(en)
|
2005-03-15 |
2006-09-28 |
Bp Corporation North America Inc. |
Cellulases, nucleic acids encoding them and methods for making and using them
|
EP1924282B1
(en)
|
2005-08-15 |
2017-01-11 |
Altimmune Inc. |
Immunization of avians by administration of non-replicating vectored vaccines
|
CA2621083C
(en)
|
2005-08-30 |
2017-04-11 |
University Of Miami |
Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
|
JP2009507227A
(ja)
|
2005-09-02 |
2009-02-19 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
メラノーマを診断するための方法及びプローブ組み合わせ
|
US20090324574A1
(en)
|
2006-02-02 |
2009-12-31 |
Verenium Corporation |
Esterases and Related Nucleic Acids and Methods
|
NZ571087A
(en)
|
2006-02-10 |
2012-04-27 |
Verenium Corp |
Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them
|
USRE45660E1
(en)
|
2006-02-14 |
2015-09-01 |
Bp Corporation North America Inc. |
Xylanases, nucleic acids encoding them and methods for making and using them
|
BR122017003017B1
(pt)
|
2006-03-07 |
2018-10-23 |
Basf Enzymes Llc |
Ácido nucléico, cassete de expressão, vetor, veículo de clonagem, microrganismotransgênico, polipeptídeo, peptídeo sinal, composição, e métodos para produzir um polipeptídeo recombinante, para gerar uma variante de um ácido nucléico, para clivar uma ligação carbono-carbono em uma composição, para formar uma ligação carbono-carbono,para fazer um gênero alimentício, uma ração ou bebida, e para converter uma biomassa ouqualquer material lignocelulósico em um combustível
|
CN101437954B
(zh)
|
2006-03-07 |
2015-09-09 |
嘉吉公司 |
醛缩酶和编码醛缩酶的核酸以及它们的制备和使用方法
|
DK3235811T3
(en)
|
2006-04-21 |
2018-11-12 |
Senomyx Inc |
PROCEDURE FOR THE PREPARATION OF OXALAMIDS
|
DK2069389T3
(en)
|
2006-08-04 |
2015-01-12 |
Bp Corp North America Inc |
Glucanases, nucleic acids encoding them, and processes for their preparation and use
|
WO2008036863A2
(en)
|
2006-09-21 |
2008-03-27 |
Verenium Corporation |
Phospholipases, nucleic acids encoding them and methods for making and using them
|
PL2617823T3
(pl)
|
2006-09-21 |
2015-12-31 |
Basf Enzymes Llc |
Fitazy, kodujące je kwasy nukleinowe oraz sposoby ich wytwarzania i stosowania
|
ES2620288T3
(es)
|
2006-12-21 |
2017-06-28 |
Basf Enzymes Llc |
Amilasas y glucoamilasas, ácidos nucleicos que las codifican y métodos para formarlas y utilizarlas
|
WO2008095033A2
(en)
|
2007-01-30 |
2008-08-07 |
Verenium Corporation |
Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
|
CA3017478A1
(en)
|
2007-04-27 |
2008-11-06 |
The Regents Of The University Of California |
Plant co2 sensors, nucleic acids encoding them, and methods for making and using them
|
BRPI0817811A2
(pt)
|
2007-10-03 |
2014-10-14 |
Verenium Corp |
Xilanases, ácidos nucleicos que codificam as mesmas e métodos para fabricação e uso das mesmas.
|
CA2702494A1
(en)
|
2007-10-19 |
2009-04-23 |
The Regents Of The University Of California |
Compositions and methods for ameliorating cns inflammation, psychosis, delirium, ptsd or ptss
|
PL2238242T3
(pl)
|
2008-01-03 |
2015-06-30 |
Basf Enzymes Llc |
Transferazy i oksydoreduktazy, kwasy nukleinowe kodujące je oraz sposoby ich wytwarzania i zastosowania
|
CA2710922A1
(en)
|
2008-01-03 |
2009-07-16 |
Verenium Corporation |
Isomerases, nucleic acids encoding them and methods for making and using them
|
EP2288379A4
(en)
|
2008-05-19 |
2012-08-08 |
Advaxis |
DOUBLE RELEASE SYSTEM FOR HETEROLOGIST ANTIGENE
|
US9084747B2
(en)
|
2009-11-11 |
2015-07-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of HER2/NEU over-expressing tumors
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
US8609371B2
(en)
|
2008-08-12 |
2013-12-17 |
Allylix, Inc. |
Isoprenoid compounds
|
US8198062B2
(en)
|
2008-08-29 |
2012-06-12 |
Dsm Ip Assets B.V. |
Hydrolases, nucleic acids encoding them and methods for making and using them
|
BRPI0913475B8
(pt)
|
2008-09-15 |
2019-05-07 |
Genentech Inc |
vetor
|
CA2744987C
(en)
|
2008-12-02 |
2018-01-16 |
Chiralgen, Ltd. |
Method for the synthesis of phosphorus atom modified nucleic acids
|
HUE028642T2
(en)
|
2009-04-20 |
2016-12-28 |
Galen Bio Inc |
Preparations for incorporating biomolecules into cells
|
AU2010249500B2
(en)
|
2009-05-21 |
2016-03-24 |
Basf Enzymes Llc |
Phytases, nucleic acids encoding them and methods for making and using them
|
BR112012000828A8
(pt)
|
2009-07-06 |
2017-10-10 |
Ontorii Inc |
Novas pró-drogas de ácido nucleico e métodos de uso das mesmas
|
US20120121589A1
(en)
|
2009-07-13 |
2012-05-17 |
Wayne State University |
Modified egfr ectodomain
|
KR20120089259A
(ko)
|
2009-08-03 |
2012-08-09 |
유니버시티 오브 마이애미 |
T 조절 세포의 생체 내 확장 방법
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
UA111708C2
(uk)
|
2009-10-16 |
2016-06-10 |
Бандж Ойлз, Інк. |
Спосіб рафінування олії
|
WO2011048495A1
(en)
|
2009-10-19 |
2011-04-28 |
Stichting Het Nederlands Kanker Instituut |
Predicting benefit of anti-cancer therapy via array comparative genomic hybridization
|
WO2011048498A2
(en)
|
2009-10-19 |
2011-04-28 |
Stichting Het Nederlands Kanker Instituut |
Differentiation between brca2-associated tumours and sporadic tumours via array comparative genomic hybridization
|
EP2491140A1
(en)
|
2009-10-19 |
2012-08-29 |
Stichting Het Nederlands Kanker Instituut |
Predicting response to anti-cancer therapy via array comparative genomic hybridization
|
WO2011056505A1
(en)
|
2009-10-26 |
2011-05-12 |
Abbott Laboratories |
Detection of chromosomal abnormalities associated with prognosis of non small cell lung cancer
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
ES2621812T3
(es)
|
2010-05-10 |
2017-07-05 |
Mayo Foundation For Medical Education And Research |
Detección de anomalías cromosómicas asociadas con el cáncer endometrial
|
US20140018251A1
(en)
|
2010-09-20 |
2014-01-16 |
Stichting Het Nederlands Kanker Instituut |
Methods for Predicting Response to Anti-Cancer Therapy in Cancer Patients
|
US10428019B2
(en)
|
2010-09-24 |
2019-10-01 |
Wave Life Sciences Ltd. |
Chiral auxiliaries
|
JP5981436B2
(ja)
|
2010-10-01 |
2016-08-31 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
寄生的に感染している対象におけるワクチン不応答性を反転させるためのリステリアワクチンベクターの使用
|
CA2811789A1
(en)
|
2010-10-06 |
2012-04-12 |
Bp Corporation North America Inc. |
Variant cbh i polypeptides with reduced product inhibition
|
WO2012083240A2
(en)
|
2010-12-16 |
2012-06-21 |
Dana-Farber Cancer Institute, Inc. |
Oligonucleotide array for tissue typing
|
CA2829960A1
(en)
|
2011-03-11 |
2012-09-20 |
John Rothman |
Listeria-based adjuvants
|
RU2014105311A
(ru)
|
2011-07-19 |
2015-08-27 |
Уэйв Лайф Сайенсес Пте. Лтд. |
Способы синтеза функционализованных нуклеиновых кислот
|
US8450107B1
(en)
|
2011-11-30 |
2013-05-28 |
The Broad Institute Inc. |
Nucleotide-specific recognition sequences for designer TAL effectors
|
US9745631B2
(en)
|
2011-12-20 |
2017-08-29 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
WO2013124740A2
(en)
|
2012-02-23 |
2013-08-29 |
Stichting Vu-Vumc |
BRCA DEFICIENCY PROTEIN AND mRNA SIGNATURES USEFUL IN IDENTIFICATION OF PATIENTS WITH BRCA-DEFICIENT TUMORS AND PREDICTING BENEFIT OF ANTI-CANCER THERAPY IN CANCER PATIENTS
|
BR112014022662A2
(pt)
|
2012-03-12 |
2017-10-03 |
Advaxis Inc |
Inibição da função de célula supressora seguindo tratamento de vacina de listeria
|
US10138479B2
(en)
|
2012-05-24 |
2018-11-27 |
Dana-Farber Cancer Institute, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
|
CA2875236A1
(en)
|
2012-06-22 |
2013-12-27 |
Julian I. Schroeder |
Compositions and methods for mediating plant stomatal development in response to carbon dioxide and applications for engineering drought tolerance in plants
|
SG10201912895PA
(en)
|
2012-07-13 |
2020-02-27 |
Wave Life Sciences Ltd |
Chiral control
|
MX356830B
(es)
|
2012-07-13 |
2018-06-15 |
Shin Nippon Biomedical Laboratories Ltd |
Adyuvante de acido nucleico quiral.
|
WO2014012090A1
(en)
|
2012-07-13 |
2014-01-16 |
The Broad Institute, Inc. |
Molecular sleds comprising a positively-charged amino acid sequence and a molecular cargo and uses thereof
|
JP6268157B2
(ja)
|
2012-07-13 |
2018-01-24 |
株式会社Wave Life Sciences Japan |
不斉補助基
|
US20150285802A1
(en)
|
2012-07-18 |
2015-10-08 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
PT3494997T
(pt)
|
2012-07-25 |
2019-12-05 |
Massachusetts Inst Technology |
Proteínas de ligação a adn indutíveis e ferramentas de perturbação do genoma e aplicações destas
|
ES2658401T3
(es)
|
2012-12-12 |
2018-03-09 |
The Broad Institute, Inc. |
Suministro, modificación y optimización de sistemas, métodos y composiciones para la manipulación de secuencias y aplicaciones terapéuticas
|
EP2931899A1
(en)
|
2012-12-12 |
2015-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions, methods, knock out libraries and applications thereof
|
PL2784162T3
(pl)
|
2012-12-12 |
2016-01-29 |
Broad Inst Inc |
Opracowanie systemów, metod oraz zoptymalizowanych kompozycji przewodnikowych do manipulacji sekwencyjnej
|
EP2931892B1
(en)
|
2012-12-12 |
2018-09-12 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
DK2898075T3
(en)
|
2012-12-12 |
2016-06-27 |
Broad Inst Inc |
CONSTRUCTION AND OPTIMIZATION OF IMPROVED SYSTEMS, PROCEDURES AND ENZYME COMPOSITIONS FOR SEQUENCE MANIPULATION
|
ES2576128T3
(es)
|
2012-12-12 |
2016-07-05 |
The Broad Institute, Inc. |
Modificación por tecnología genética y optimización de sistemas, métodos y composiciones para la manipulación de secuencias con dominios funcionales
|
KR102565827B1
(ko)
|
2013-01-09 |
2023-08-11 |
유니버시티 오브 마이애미 |
TL1A-Ig 융합 단백질을 사용한 T 조절 세포의 조절을 위한 조성물 및 방법
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
WO2014204725A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
|
ES2777217T3
(es)
|
2013-06-17 |
2020-08-04 |
Broad Inst Inc |
Suministro, modificación y optimización de sistemas de guía en tándem, métodos y composiciones para la manipulación de secuencias
|
EP3011034B1
(en)
|
2013-06-17 |
2019-08-07 |
The Broad Institute, Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components
|
DK3011032T3
(da)
|
2013-06-17 |
2020-01-20 |
Broad Inst Inc |
Fremføring, modificering og optimering af systemer, fremgangsmåder og sammensætninger til målretning mod og modellering af sygdomme og forstyrrelser i postmitotiske celler
|
KR20160030187A
(ko)
|
2013-06-17 |
2016-03-16 |
더 브로드 인스티튜트, 인코퍼레이티드 |
간의 표적화 및 치료를 위한 CRISPRCas 시스템, 벡터 및 조성물의 전달 및 용도
|
WO2015050844A1
(en)
|
2013-10-01 |
2015-04-09 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancer with atovaquone-related compounds
|
WO2015057671A1
(en)
|
2013-10-14 |
2015-04-23 |
The Broad Institute, Inc. |
Artificial transcription factors comprising a sliding domain and uses thereof
|
US10655173B2
(en)
|
2013-10-18 |
2020-05-19 |
The Broad Institute, Inc. |
Spatial and cellular mapping of biomolecules in situ by high-throughput sequencing
|
WO2015089473A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Engineering of systems, methods and optimized guide compositions with new architectures for sequence manipulation
|
MX2016007327A
(es)
|
2013-12-12 |
2017-03-06 |
Broad Inst Inc |
Suministro, uso y aplicaciones terapeuticas de sistemas y composiciones crispr-cas para dirigirlos a trastornos y enfermedades usando componentes para suministro de particulas.
|
MX2016007324A
(es)
|
2013-12-12 |
2017-03-06 |
Broad Inst Inc |
Suministro, uso y aplicaciones terapeuticas de los sistemas y composiciones crispr-cas para actuar sobre hbv y trastornos y enfermedades virales.
|
KR20160089527A
(ko)
|
2013-12-12 |
2016-07-27 |
더 브로드 인스티튜트, 인코퍼레이티드 |
게놈 편집을 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료적 응용
|
WO2015089354A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Compositions and methods of use of crispr-cas systems in nucleotide repeat disorders
|
WO2015089364A1
(en)
|
2013-12-12 |
2015-06-18 |
The Broad Institute Inc. |
Crystal structure of a crispr-cas system, and uses thereof
|
JPWO2015108046A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤
|
WO2015108048A1
(ja)
|
2014-01-15 |
2015-07-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
JPWO2015108047A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤
|
KR102423317B1
(ko)
|
2014-01-16 |
2022-07-22 |
웨이브 라이프 사이언시스 리미티드 |
키랄 디자인
|
AU2015218903B2
(en)
|
2014-02-20 |
2020-10-15 |
Allergan, Inc. |
Complement component C5 antibodies
|
KR20160126054A
(ko)
|
2014-02-27 |
2016-11-01 |
알러간, 인코포레이티드 |
보체 인자 Bb 항체
|
WO2015138803A1
(en)
|
2014-03-12 |
2015-09-17 |
Icahn School Of Medicine At Mount Sinai |
Method for identifying kidney allograft recipients at risk for chronic injury
|
WO2015149006A2
(en)
|
2014-03-27 |
2015-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
|
US11572587B2
(en)
|
2014-06-26 |
2023-02-07 |
Icahn School Of Medicine At Mount Sinai |
Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets
|
CN114984228A
(zh)
|
2014-07-18 |
2022-09-02 |
阿德瓦希斯股份有限公司 |
用于治疗前列腺癌的pd-1拮抗剂和基于李斯特菌的疫苗的组合
|
EP3180426B1
(en)
|
2014-08-17 |
2019-12-25 |
The Broad Institute, Inc. |
Genome editing using cas9 nickases
|
WO2016049024A2
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling competition of multiple cancer mutations in vivo
|
WO2016049251A1
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for modeling mutations in leukocytes
|
WO2016049163A2
(en)
|
2014-09-24 |
2016-03-31 |
The Broad Institute Inc. |
Use and production of chd8+/- transgenic animals with behavioral phenotypes characteristic of autism spectrum disorder
|
WO2016049258A2
(en)
|
2014-09-25 |
2016-03-31 |
The Broad Institute Inc. |
Functional screening with optimized functional crispr-cas systems
|
WO2016094872A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Dead guides for crispr transcription factors
|
WO2016094874A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Escorted and functionalized guides for crispr-cas systems
|
EP3985115A1
(en)
|
2014-12-12 |
2022-04-20 |
The Broad Institute, Inc. |
Protected guide rnas (pgrnas)
|
WO2016094880A1
(en)
|
2014-12-12 |
2016-06-16 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of crispr systems and compositions for genome editing as to hematopoietic stem cells (hscs)
|
JP6689279B2
(ja)
*
|
2014-12-16 |
2020-05-20 |
ロシュ イノベーション センター コペンハーゲン エーエス |
キラル毒性のスクリーニング方法
|
EP3234192B1
(en)
|
2014-12-19 |
2021-07-14 |
The Broad Institute, Inc. |
Unbiased identification of double-strand breaks and genomic rearrangement by genome-wide insert capture sequencing
|
WO2016106236A1
(en)
|
2014-12-23 |
2016-06-30 |
The Broad Institute Inc. |
Rna-targeting system
|
CA2970370A1
(en)
|
2014-12-24 |
2016-06-30 |
Massachusetts Institute Of Technology |
Crispr having or associated with destabilization domains
|
WO2016108926A1
(en)
|
2014-12-30 |
2016-07-07 |
The Broad Institute Inc. |
Crispr mediated in vivo modeling and genetic screening of tumor growth and metastasis
|
EP3298172B1
(en)
|
2015-05-22 |
2023-07-26 |
The Regents of The University of California |
Determining risk of prostate cancer recurrence
|
WO2016205728A1
(en)
|
2015-06-17 |
2016-12-22 |
Massachusetts Institute Of Technology |
Crispr mediated recording of cellular events
|
WO2016205749A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
WO2016205745A2
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Cell sorting
|
CA3012631A1
(en)
|
2015-06-18 |
2016-12-22 |
The Broad Institute Inc. |
Novel crispr enzymes and systems
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
US20170211142A1
(en)
|
2015-10-22 |
2017-07-27 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
WO2017075294A1
(en)
|
2015-10-28 |
2017-05-04 |
The Board Institute Inc. |
Assays for massively combinatorial perturbation profiling and cellular circuit reconstruction
|
US20190233814A1
(en)
|
2015-12-18 |
2019-08-01 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
AU2017257274B2
(en)
|
2016-04-19 |
2023-07-13 |
Massachusetts Institute Of Technology |
Novel CRISPR enzymes and systems
|
EP3445848A1
(en)
|
2016-04-19 |
2019-02-27 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
CA3026112A1
(en)
|
2016-04-19 |
2017-10-26 |
The Broad Institute, Inc. |
Cpf1 complexes with reduced indel activity
|
JP7267013B2
(ja)
|
2016-06-17 |
2023-05-01 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
Vi型crisprオルソログ及び系
|
WO2018005873A1
(en)
|
2016-06-29 |
2018-01-04 |
The Broad Institute Inc. |
Crispr-cas systems having destabilization domain
|
CN110312799A
(zh)
|
2016-08-17 |
2019-10-08 |
博德研究所 |
新型crispr酶和系统
|
WO2018074979A1
(en)
|
2016-10-17 |
2018-04-26 |
Nanyang Technological University |
Truncated crispr-cas proteins for dna targeting
|
KR102185464B1
(ko)
|
2017-03-15 |
2020-12-03 |
매사추세츠 인스티튜트 오브 테크놀로지 |
신규 cas13b 오르소로그 crispr 효소 및 시스템
|
US11840711B2
(en)
|
2017-04-12 |
2023-12-12 |
The Broad Institute, Inc. |
Type VI CRISPR orthologs and systems
|
US20210278416A1
(en)
|
2017-05-09 |
2021-09-09 |
The Broad Institute, Inc. |
Gut microbiome function predicts response to anti-integrin biologic therapy in inflammatory bowel diseases
|
WO2018236548A1
(en)
|
2017-06-23 |
2018-12-27 |
Inscripta, Inc. |
NUCLEIC ACID GUIDED NUCLEASES
|
WO2019089803A1
(en)
|
2017-10-31 |
2019-05-09 |
The Broad Institute, Inc. |
Methods and compositions for studying cell evolution
|
WO2019113506A1
(en)
|
2017-12-07 |
2019-06-13 |
The Broad Institute, Inc. |
Methods and compositions for multiplexing single cell and single nuclei sequencing
|
CN112236137A
(zh)
|
2018-04-16 |
2021-01-15 |
西奈山伊坎医学院 |
利用移植前接受者血液中转录组标志预测急性排斥反应和肾脏同种异体移植物丧失的方法和试剂盒
|
WO2020041380A1
(en)
|
2018-08-20 |
2020-02-27 |
The Broad Institute, Inc. |
Methods and compositions for optochemical control of crispr-cas9
|
US20220235340A1
(en)
|
2019-05-20 |
2022-07-28 |
The Broad Institute, Inc. |
Novel crispr-cas systems and uses thereof
|
KR20220044811A
(ko)
|
2019-08-16 |
2022-04-11 |
메사추세츠 인스티튜트 오브 테크놀로지 |
Crispr/cas13을 사용하는 표적화된 트랜스-이어맞추기
|
BR112022025416A2
(pt)
|
2020-06-25 |
2023-01-24 |
Mycotechnology Inc |
Proteína doce de trufa
|
US11248265B1
(en)
|
2020-11-19 |
2022-02-15 |
Clear Labs, Inc |
Systems and processes for distinguishing pathogenic and non-pathogenic sequences from specimens
|
JP2023551404A
(ja)
|
2020-11-20 |
2023-12-08 |
レビビコア, インコーポレイテッド |
異種間移植のための成長ホルモン受容体ノックアウトを有する多重トランスジェニックブタ
|
US20230045095A1
(en)
|
2021-06-23 |
2023-02-09 |
Massachusetts Institute Of Technology |
Compositions, Methods and Systems for the Delivery of Gene Editing Material to Cells
|
CA3232376A1
(en)
|
2021-09-20 |
2023-03-23 |
Maria KOKKINAKI |
Multitransgenic pigs comprising ten genetic modifications for xenotransplantation
|
WO2023141602A2
(en)
|
2022-01-21 |
2023-07-27 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2023185697A2
(en)
|
2022-03-29 |
2023-10-05 |
Accuredit Therapeutics (Suzhou) Co., Ltd. |
Compositions and methods for treatment of transthyretin amyloidosis
|
GB202208575D0
(en)
|
2022-06-13 |
2022-07-27 |
Univ Edinburgh |
Activation of noncoding host gene loci
|
WO2024020346A2
(en)
|
2022-07-18 |
2024-01-25 |
Renagade Therapeutics Management Inc. |
Gene editing components, systems, and methods of use
|
WO2024044723A1
(en)
|
2022-08-25 |
2024-02-29 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2024061296A2
(en)
|
2022-09-22 |
2024-03-28 |
Accuredit Therapeutics (Suzhou) Co., Ltd. |
Compositions and methods for treatment of hypercholesterolemia and/or cardiovascular disease
|